ANTITHROMBOTIC THERAPY IN THE PRIMARY AND SECONDARY PREVENTION OF CORONARY-RELATED DEATH AND INFARCTION - FOCUS ON GENDER DIFFERENCES

被引：6

作者：

CLYNE, CA ^{[1
]}

机构：

[1] UNIV MASSACHUSETTS, MED CTR, DEPT INTERNAL MED, DIV CARDIOVASC MED, WORCESTER, MA 01605 USA

来源：

CARDIOLOGY | 1990年 / 77卷

关键词：

Antithrombotic therapy; Coronary artery disease; Myocardial infarction; Prevention;

D O I：

10.1159/000174658

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Much of our understanding of the role of antithrombotic therapy for postmyocardial infarction patients comes from studies which often included few or no women. Despite this shortcoming there are data available which identify gender differences in risk factors, presentation, natural history and treatment results for myocardial infarction. The use of anticoagulants and antiplatelet agents in the prevention and management of myocardial infarction has evolved over 30 years of investigation. The major randomized, controlled and blinded studies of antithrombotics and myocardial infarction are reviewed, with special emphasis on the female population.

引用

页码：99 / 109

页数：11

共 50 条

[21] GENDER-RELATED DIFFERENCES IN CORONARY ANGIOGRAMS OF YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION
NEGUS, BH
WILLARD, JE
GLAMANN, DB
LANDAU, C
SNYDER, RW
HILLIS, LD
LANGE, RA
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (08): : 814 - 815
[22] Secondary prevention of coronary heart disease and gender perspective in two primary healthcare centers
Ribera i Osca, Joan Antoni
Peiro, Salvador
MEDICINA CLINICA, 2006, 127 (08): : 286 - 288
[23] Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective
White, Harvey D.
EUROPEAN HEART JOURNAL, 2019, 40 (24) : E4 - E7
[24] Update on oral antithrombotic therapy for secondary prevention following non-ST segment elevation myocardial infarction
Park, Yongwhi
Franchi, Francesco
Rollini, Fabiana
Angiolillo, Dominick J.
TRENDS IN CARDIOVASCULAR MEDICINE, 2016, 26 (04) : 321 - 334
[25] Secondary Prevention After Acute Myocardial Infarction and Coronary Revascularisation: Focus on Angiotensin Converting Enzyme Inhibitors
Juan Carlos Kaski
Daniel Fernandez-Berges
Cardiovascular Drugs and Therapy, 2008, 22
[26] Secondary prevention after acute myocardial infarction and coronary revascularisation: Focus on angiotensin converting enzyme inhibitors
Kaski, Juan Carlos
Fernandez-Berges, Daniel
CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (03) : 185 - 191
[27] THE STATUS OF HORMONAL THERAPY FOR THE PRIMARY AND SECONDARY PREVENTION OF ATHEROSCLEROTIC CORONARY HEART DISEASE
STAMLER, J
BEST, MM
TURNER, JD
PROGRESS IN CARDIOVASCULAR DISEASES, 1963, 6 (03) : 220 - 235
[28] Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study
Sobers, Natasha
Rose, Angela M. C.
Samuels, T. Alafia
Critchley, Julia
Abed, Melissa
Hambleton, Ian
Harvey, Arianne
Unwin, Nigel
BMJ OPEN, 2019, 9 (01):
[29] Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention
Mombelli, Giuliana
Bosisio, Raffaella
Calabresi, Laura
Magni, Paolo
Pavanello, Chiara
Pazzucconi, Franco
Sirtori, Cesare R.
JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) : 226 - 233
[30] Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
Husted, Steen
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 263 - 277

← 1 2 3 4 5 →